- Home
- / Intra-Cellular Therapies
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Intra-Cellular Therapies financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$76.8
2024-10-29
Market Capitalization
$8.1 B
2024-10-29
Revenue
$680.9 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.7M | 577.3K | 91.4K | 330.7K | 245.8K | 60.6K | 22.8M | 83.8M | 250.3M | 464.4M | 680.9M | |
| Revenue growth, % | -78.9% | -84.2% | 262.0% | |||||||||
| General and administrative expense | 6.0M | 10.3M | 18.2M | 24.8M | 23.7M | 30.1M | 64.9M | 186.4M | 272.6M | 358.8M | 409.9M | 504.5M |
| Operating expense total | 29.0M | 31.6M | 105.9M | 118.6M | 103.1M | 162.3M | 154.1M | 252.1M | 493.5M | 590.0M | 740.6M | |
| EBIT | (26.3M) | (31.0M) | (105.8M) | (118.3M) | (102.8M) | (162.3M) | (154.0M) | (231.2M) | (285.7M) | (263.6M) | (159.4M) | (116.7M) |
| EBIT margin, % | -959.7% | -5367.5% | -115815.9% | -35760.0% | -41832.6% | -254090.5% | -1013.6% | -105.3% | -34.3% | -17.1% | ||
| Interest income | 29.6K | 303.9K | 1.0M | 1.6M | 7.4M | 20.3M | 42.5M | |||||
| Interest expense | 36.8K | |||||||||||
| Pre tax profit | (115.4M) | (98.8M) | (155.1M) | (147.7M) | (227.0M) | (284.1M) | (256.2M) | (139.0M) | (74.2M) | |||
| Income tax expense | 18.0K | 1.6K | 1.6K | 1.1M | (1.1M) | 1.6K | 1.6K | 13.5K | 5.6K | 6.0K | 636.0K | 473.0K |
| Net Income | (26.9M) | (30.7M) | (104.8M) | (116.4M) | (97.8M) | (155.1M) | (147.7M) | (227.0M) | (284.1M) | (256.3M) | (139.7M) | (74.7M) |
| EPS | (2.7) | (1.5) | (0.7) |